Correlation Between Kiora Pharmaceuticals and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Unicycive Therapeutics, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Unicycive Therapeutics.
Diversification Opportunities for Kiora Pharmaceuticals and Unicycive Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Kiora and Unicycive is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Unicycive Therapeutics
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 2.12 times less risky than Unicycive Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 51.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 17.00 from holding Unicycive Therapeutics or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Unicycive Therapeutics
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Unicycive Therapeutics |
Kiora Pharmaceuticals and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Unicycive Therapeutics
The main advantage of trading using opposite Kiora Pharmaceuticals and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |